Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent or Progressive Diffuse Malignant Peritoneal Mesothelioma: Clinicopathologic Characteristics and Survival Outcome

@article{Ihemelandu2014IterativeCS,
  title={Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent or Progressive Diffuse Malignant Peritoneal Mesothelioma: Clinicopathologic Characteristics and Survival Outcome},
  author={Facs Chukwuemeka Ihemelandu and Facs Lana Bijelic and Facs Frcs Paul H. Sugarbaker},
  journal={Annals of Surgical Oncology},
  year={2014},
  volume={22},
  pages={1680-1685}
}
Diffuse malignant peritoneal mesothelioma (DMPM) is an aggressive disease for which cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been used with remarkable survival benefits. Our aim was to analyze the clinicopathologic characteristics and prognosis of recurrent DMPM managed with iterative CRS and HIPEC. A retrospective analysis of a prospectively maintained database for all patients treated for DMPM from 1989 to 2012. Of 205 consecutive CRS and HIPEC… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

An overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy

  • PH Sugarbaker
  • Textbook and Video Atlas. Woodbury; Cine-Med;
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…